Fig. 1From: Benefit-risk assessment of traditional Chinese medicine preparations of sinomenine using multicriteria decision analysis (MCDA) for patients with rheumatoid arthritisBenefit-risk evaluation effects tree of sinomenine in the treatment of RA. Benefit: Positive outcomes for patients Risk: Negative outcomes for patients TJC: tender joint count SJC: swollen joint count RF: rheumatoid factor CRP: C-reactive protein ESR: erythrocyte sedimentation rateBack to article page